Search - tctmd.com

Displaying 181 - 200 of 224

Sort: Relevancy | Date

News Industry News

Medtronic Drug-Coated Balloon Receives FDA Approval for Treating Peripheral Artery Disease in Upper Leg

January 04, 2015

News Daily News

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

Salynn Boyles

December 15, 2014

News Daily News

OCTOPUS: Combo of BMS Plus Paclitaxel Balloon Appears Safe But May Be Outdated

December 14, 2014

News Daily News

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

Caitlin E. Cox

October 24, 2014

News Conference News TCT 2014

PEPCAD-DES at 3 Years: Paclitaxel-Coated Balloon Holds Advantage for DES Restenosis

September 13, 2014

News Industry News

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

September 10, 2014

News Industry News

Boston Scientific Receives CE Mark For Ranger™ Drug-Coated Balloon

July 14, 2014

News Daily News

Un Panel Asesor de la FDA Aprueba un Balón recubierto de Paclitaxel para el Manejo de la Enfermedad Femoropoplítea

L.A. McKeown

June 17, 2014

News Daily News

FDA Advisory Panel Gives Nod to Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

L.A. McKeown

June 17, 2014

News Industry News

Medtronic Submits Final Data to FDA for Novel Device to Treat Peripheral Artery Disease

June 11, 2014

News Daily News

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

April 14, 2014

News Daily News

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

Yael L. Maxwell

February 26, 2014

News Daily News

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

Jason Kahn

February 20, 2014

News Conference News TCT 2013

Drug-coated Balloons May Become Standard of Care in ISR

October 31, 2013

News Industry News

New Study Examines Safety and Efficacy of Drug Coated Balloon Angioplasty for Treatment of Femoropopliteal Artery Disease

October 30, 2013

News Conference News TCT 2013

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

October 30, 2013

News Conference News TCT 2013

Paclitaxel-Coated Balloons Show Promise in Two Studies

October 29, 2013

News Daily News

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

October 15, 2013

News Daily News

Drug-eluting Balloon Bests Angioplasty for In-stent Restenosis

Jason Kahn

September 27, 2013

News Daily News

Oral Sirolimus Appears to Augment Efficacy of BMS

Caitlin E. Cox

August 23, 2013

Advertisement

Medtronic Drug-Coated Balloon Receives FDA Approval for Treating Peripheral Artery Disease in Upper Leg

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

OCTOPUS: Combo of BMS Plus Paclitaxel Balloon Appears Safe But May Be Outdated

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

PEPCAD-DES at 3 Years: Paclitaxel-Coated Balloon Holds Advantage for DES Restenosis

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

Boston Scientific Receives CE Mark For Ranger™ Drug-Coated Balloon

Un Panel Asesor de la FDA Aprueba un Balón recubierto de Paclitaxel para el Manejo de la Enfermedad Femoropoplítea

FDA Advisory Panel Gives Nod to Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

Medtronic Submits Final Data to FDA for Novel Device to Treat Peripheral Artery Disease

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

Drug-coated Balloons May Become Standard of Care in ISR

New Study Examines Safety and Efficacy of Drug Coated Balloon Angioplasty for Treatment of Femoropopliteal Artery Disease

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

Paclitaxel-Coated Balloons Show Promise in Two Studies

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

Drug-eluting Balloon Bests Angioplasty for In-stent Restenosis

Oral Sirolimus Appears to Augment Efficacy of BMS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content